TrialThorax2026

Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.

Judith Prochaska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.